JP2004521911A5 - - Google Patents

Download PDF

Info

Publication number
JP2004521911A5
JP2004521911A5 JP2002565625A JP2002565625A JP2004521911A5 JP 2004521911 A5 JP2004521911 A5 JP 2004521911A5 JP 2002565625 A JP2002565625 A JP 2002565625A JP 2002565625 A JP2002565625 A JP 2002565625A JP 2004521911 A5 JP2004521911 A5 JP 2004521911A5
Authority
JP
Japan
Prior art keywords
albumin
lipopeptides
lipoproteins
grant
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002565625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004521911A (ja
Filing date
Publication date
Priority claimed from GBGB0103877.7A external-priority patent/GB0103877D0/en
Application filed filed Critical
Publication of JP2004521911A publication Critical patent/JP2004521911A/ja
Publication of JP2004521911A5 publication Critical patent/JP2004521911A5/ja
Pending legal-status Critical Current

Links

JP2002565625A 2001-02-16 2002-02-15 投薬方式 Pending JP2004521911A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0103877.7A GB0103877D0 (en) 2001-02-16 2001-02-16 Novel Drug Delivery system
PCT/GB2002/000680 WO2002066067A2 (en) 2001-02-16 2002-02-15 Albumin-based drug delivery system and antimicrobial peptides

Publications (2)

Publication Number Publication Date
JP2004521911A JP2004521911A (ja) 2004-07-22
JP2004521911A5 true JP2004521911A5 (enExample) 2005-06-02

Family

ID=9908913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002565625A Pending JP2004521911A (ja) 2001-02-16 2002-02-15 投薬方式

Country Status (7)

Country Link
US (1) US20040110678A1 (enExample)
EP (1) EP1359941A2 (enExample)
JP (1) JP2004521911A (enExample)
AU (1) AU2002229994A1 (enExample)
CA (1) CA2476397A1 (enExample)
GB (1) GB0103877D0 (enExample)
WO (1) WO2002066067A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
WO2005013885A2 (en) 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
WO2007026356A2 (en) * 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
WO2008128251A1 (en) * 2007-04-17 2008-10-23 The Children's Hospital Of Philadelphia Humanized viral vectors and methods of use thereof
EP2653166A3 (en) * 2007-07-30 2014-08-27 Healor Ltd. Pharmaceutical composition and related methods
ES2601827T3 (es) * 2009-02-24 2017-02-16 Arava Bio-Tech Ltd. Agentes antagonistas de visfatina para el tratamiento del acné y de otras afecciones
WO2011083483A2 (en) 2010-01-11 2011-07-14 Healor Ltd. Method for treatment of inflammatory disease and disorder
AT509192B1 (de) * 2010-06-24 2011-07-15 Zentrum Fuer Biomedizinische Technologie Der Donau Uni Krems Sorptionsmittel für endotoxine
ES2800983T3 (es) * 2010-12-22 2021-01-07 Baxalta GmbH Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína
FR3002452B1 (fr) * 2013-02-28 2016-02-12 Dermaconcept Jmc Composition dermatologique antimicrobienne topique
WO2015136311A1 (en) * 2014-03-13 2015-09-17 The Secretary Of State For Health Antimicrobial conjugates, method for production and uses thereof
US10071141B2 (en) * 2015-05-08 2018-09-11 Spectral Platforms, Inc. Albumin-based non-covalent complexes and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001476A1 (en) * 1990-07-26 1992-02-06 University Of Iowa Research Foundation Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
CA2267179A1 (en) * 1996-09-26 1998-04-02 The University Of Southern California Methods and compositions for lipidization of hydrophilic molecules
WO2000033884A1 (en) * 1998-12-04 2000-06-15 Oregon Health Sciences University Conjugates of lipids and antimicrobial or antineoplastic drugs
CA2375502A1 (en) * 1999-06-23 2000-12-28 The Wistar Institute Of Anatomy & Biology Novel pyrrhocoricin-derived peptides, and methods of use thereof
DE10012120A1 (de) * 2000-03-13 2001-09-27 Ktb Tumorforschungs Gmbh Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel

Similar Documents

Publication Publication Date Title
CY1113322T1 (el) 3-{(3R,4R)-4-ΜΕΘΥΛ-3-[ΜΕΘΥΛ-(7Η-ΠΥΡΡΟΛΟ[2,3-d]ΠΥΡΙΜΙΔΙΝ-4-ΥΛ)-ΑΜΙΝΟ]-ΠΙΠΕΡΙΔΙΝΥΛ}-3-ΟΞΟ-ΠΡΟΠΙΟΝΙΤΡΙΛΙΟ ΩΣ ΑΝΑΣΤΟΛΕΑΣ ΚΙΝΑΣΩΝ ΠΡΩΤΕΪΝΗΣ
AR031151A1 (es) Articulo absorbente
JP2004521911A5 (enExample)
RU2001111046A (ru) Пестицидные белки
USD467437S1 (en) Frame for a combined table and benches
JP2004155888A5 (enExample)
USD499907S1 (en) Base for display stand
USD467610S1 (en) Four-sided display greeting card holder
JP2004529205A5 (enExample)
DE60225022D1 (de) Formbarer copolyesterfilm
USD505281S1 (en) Table
JP2003073772A5 (enExample)
USD494184S1 (en) Portable arm and mouse support
USD539753S1 (en) T-shaped raceway base
USD480082S1 (en) Computer workstation
RU2000118409A (ru) Антимутагенное средство
SE0100319D0 (sv) Golvmatta
NO20033934L (no) Naturlig antistoff aktiv mot HIV-viruset
RU2001109481A (ru) Антиангинальное средство
USD492211S1 (en) Display testing device
JP2002201140A5 (enExample)
ITMI20022393A1 (it) Confezioni indossabili per profumi per la persona.
BR8202934U (pt) Sacola com gancho para carrinhos de compras
JP2002310240A5 (enExample)
RU2000115217A (ru) Средство для лечения хронического эндометрита